In particular, the clinical and genetic history of the LBC patient carrier of the CDH1 pathogenic variant suggests us to include male LBC in the genetic testing criteria and male breast surveillance in local and HDGC guidelines (23). Here, CDH1 is linked to CDH1-related diffuse gastric and lobular breast cancer syndrome.